$0.3879
0.01694.56%
Últ. Act.: Oct 29, 8:00 PM
cbdMD (YCBD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
cbdMD (YCBD) publicó su última previsión de noviembre 21, 2025 para Q4 2025. La compañía estimó ingresos en un rango de $4.7M - $4.9M para el período.
En comparación con la previsión anterior, cbdMD reducido redujo su previsión de ingresos desde un rango anterior de $19.1M - $19.3M.
cbdMD ha emitido 2 actualizaciones de orientación entre el noviembre 21, 2025 y el noviembre 21, 2025. During this period, the company lowered its outlook 1 time, signaling management's revised expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.05 | $-0.06 | $-0.07 |
| Actual | $-0.11 | $-0.08 | $-0.04 | $-0.08 |
| Surprise | -266.7% | -60.0% | +33.3% | -14.3% |
| Revenue | ||||
| Estimate | $5.7M | $5.3M | $4.9M | $4.7M |
| Actual | $5.6M | $5.6M | $5.0M | $4.7M |
| Surprise | -2.36% | +6.58% | +3.27% | +0.40% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.09 | $-0.06 |
| Revenue | ||
| Consensus | $5.7M | $6.3M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $-0.11 | $-0.03 | -266.7 % |
| Q2 | May 14, 2026 | $-0.08 | $-0.05 | -60.0 % |
| Q1 | Feb 17, 2026 | $-0.04 | $-0.06 | 33.3 % |
| Q4 | Dec 19, 2025 | $-0.08 | $-0.07 | -14.3 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $5.56M | $5.69M | -2.36 % |
| Q2 | May 14, 2026 | $5.64M | $5.29M | 6.58 % |
| Q1 | Feb 17, 2026 | $5.02M | $4.86M | 3.27 % |
| Q4 | Dec 19, 2025 | $4.72M | $4.70M | 0.40 % |